Search alternatives:
point decrease » point increase (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
3021
-
3022
-
3023
-
3024
-
3025
-
3026
-
3027
-
3028
Decreased s.c. growth of CNDT 2.5 cells after systemic administration of DOPC liposome-conjugated siNRP-2.
Published 2013“…NRP-2-siRNA DOPC-treatment led to a significant decrease in tumor growth compared with cntr siRNA DOPC-treatment (264.4 mm<sup>3</sup> vs. 751.3 mm<sup>3</sup>, respectively; *<i>p</i> = 0.01). …”
-
3029
-
3030
-
3031
LA decreases infarct size in rats subjected to I/R injury.
Published 2013“…<p>Representative illustrations of infarct size as stained by Evans Blue and TTC (a). LA decreased infarct size compared with I/R+V group and wortmannin pretreated group (b). …”
-
3032
LA decreases cardiomyocyte apoptosis in rats subjected to MI/R injury.
Published 2013“…<p>Representative photomicrograph showed that TUNEL-positive cardiomyocytes were more frequently observed in I/R+V group and the wortmannin-pretreated group compared with the LA group (a). …”
-
3033
-
3034
Cdk5 siRNA knockdown decreased Cdk5 activity, diminished WT1 expression and viable cell numbers, and increased cleaved caspase 3 level.
Published 2016“…E. Western blotting analysis showed a decline of WT1 expression in Cdk5 siRNA podocytes (upper panel, lane 2). …”
-
3035
-
3036
-
3037
-
3038
-
3039
-
3040